Bitcoin Bulls Eye $100K Target Amid Market Surgeby John Darbie 09.08.2024Bitcoin spikes over $62K as market rallies, igniting $100K year-end target discussions among bullish analysts.
NIS2 Directive: Boosting Innovation or Compliance Burden?by Lilu Anderson 09.08.2024Explore how the NIS2 Directive impacts cybersecurity innovation and compliance across Europe with new regulatory standards.
Dollar Strengthens as US Jobless Claims Drop Unexpectedlyby Mark Eisenberg 09.08.2024Dollar rises as US jobless claims fall, easing recession fears. Yen falls due to BOJ's stance and volatile currency trades.
Vinci Partners’ Strategic Growth in Q2 2024 Earningsby Mark Eisenberg 08.08.2024Vinci Partners reports R$61.9M fee earnings; expands private market strategies. Dividend declared amid challenging macroeconomic climate.
EU’s DORA Intensifies Bank IT Scrutiny by 2025by Lilu Anderson 08.08.2024EU's Digital Resilience Act mandates stricter IT oversight for banks and tech providers, targeting incident prevention by 2025.
Yen Falls as US Jobless Claims Exceed Expectationsby Mark Eisenberg 08.08.2024The yen declines after US jobless claims drop, easing recession fears and impacting global currency dynamics.
AI Industry Battles California’s New Safety Billby Lilu Anderson 08.08.2024AI firms challenge California bill mandating safety tests to prevent catastrophic harm, fearing impact on innovation.
Top 3 Biotech Stocks to Buy for August 2024by Lilu Anderson 08.08.2024Explore promising biotech stocks like Vertex, Pfizer, and Merck, ready to innovate and grow in the evolving healthcare landscape.
Biotech Stocks to Buy in Market Downturnby Lilu Anderson 08.08.2024Explore top biotech stocks poised for growth amid market challenges. Learn about innovations and opportunities in gene therapy.
Apple’s AI Features May Cost Up to $20by Lilu Anderson 08.08.2024Apple may charge up to $20 for premium AI features, boosting its services business with the Apple One subscription model.